Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|February 6, 2021
Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective studyDennie Meijer, Pim J van Leeuwen, Pepijn M J Oosterholt, et al.
BJUI Compass|December 12, 2025
Anatomical distribution of disease in pN1 prostate cancer with BCR post-RP: A PSMA-PET/CT-based analysisLotte G Zuur, Katelijne C C de Bie, Lieke Wever, et al.
BJU International|February 12, 2024
99mTcPSMA-radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE-II trialLotte G Zuur, Hilda A de Barros, Matthias N van Oosterom, et al.
Annals of Surgical Oncology|November 23, 2018
Internal Mammary Chain Sentinel Nodes in Early-Stage Breast Cancer Patients: Toward Selective RemovalAriane A van Loevezijn, Sanne A L Bartels, Frederieke H van Duijnhoven, et al.
European Urology Oncology|December 18, 2024
Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node DissectionRosemarijn H Ettema, Jan-Jaap J Mellema, Dennie Meijer, et al.
BJU International|August 24, 2023
Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancerYves J L Bodar, Liselotte M S Boevé, Pim J van Leeuwen, et al.
European Urology|May 24, 2021
External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter StudyDennie Meijer, Pim J van Leeuwen, Matthew J Roberts, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily PracticeJoost H H M van Riel, Maarten L Donswijk, Christel Brouwer, et al.
BJU International|October 20, 2023
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapyBart Geboers, Dennie Meijer, William Counter, et al.
BJU International|September 12, 2024
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristicsMatthew J Roberts, Nathan Papa, Hans Veerman, et al.
Pageof 8